Airline Industry Today
SEE OTHER BRANDS

Fresh airlines and aviation news from the world

Airline Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Airline Industry Today.

Press releases published on May 2, 2025

Update on Market Making Arrangements

Update on Market Making Arrangements

Reykjavík, May 02, 2025 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company” or the “Corporation”) Update on Market Making Arrangements TORONTO, ONTARIO – May 02, 2025 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mining company with a …

Jushi Holdings Inc. Updates Call Time to 4:00 p.m. Eastern Time to Report First Quarter 2025 Financial Results on May 8, 2025

Jushi Holdings Inc. Updates Call Time to 4:00 p.m. Eastern Time to Report First Quarter 2025 Financial Results on May 8, 2025

BOCA RATON, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first …

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on May 1, 2025 the Company granted inducement awards to purchase up …

Taitron Announces Quarterly Cash Dividend

Taitron Announces Quarterly Cash Dividend

LOS ANGELES, May 02, 2025 (GLOBE NEWSWIRE) -- Taitron Components Incorporated (NASDAQ:TAIT) today announced that its Board of Directors has declared a quarterly cash dividend of $0.05 per share of common stock, payable on May 30, 2025 to stockholders of …

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, …

NurExone Expands European Engagement with Investor Events in Germany and Switzerland

NurExone Expands European Engagement with Investor Events in Germany and Switzerland

TORONTO and HAIFA, Israel, May 02, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system …

Beyond Osteo Under Review: Empower Health Labs Spartan Trick for Bone Health Support Against Osteoporosis

Beyond Osteo Under Review: Empower Health Labs Spartan Trick for Bone Health Support Against Osteoporosis

New York, May 02, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: Why bone health quietly deteriorates with age and how it impacts long-term mobility The key signs and symptoms of osteoporosis that most people overlook How Empower Health Labs …

Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025

Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025

SAN CARLOS, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of non-qualified stock options to …

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NAARDEN, the Netherlands and MIAMI, May 02, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WESTLAKE VILLAGE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …

Spectral AI Schedules 2025 First Quarter Financial Results and Conference Call

Spectral AI Schedules 2025 First Quarter Financial Results and Conference Call

DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or the “Company”), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential today …

Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest

Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest

WARREN, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that, following the Company’s recent press release highlighting the Direct Registration System (DRS) as a secure method of …

GFG Closes Oversubscribed Financing

GFG Closes Oversubscribed Financing

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES SASKATOON, Saskatchewan, May 02, 2025 (GLOBE NEWSWIRE) -- GFG Resources Inc. (TSXV: GFG) (OTCQB: GFGSF) (“GFG” or the “Company”) has closed its private placement financing (the “Offering …

CarboFire Under Review: The Formula to Boost AMPK Fat Burning Metabolic Enzyme Naturally

CarboFire Under Review: The Formula to Boost AMPK Fat Burning Metabolic Enzyme Naturally

New York, May 02, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why many adults over 30 struggle with unexplained weight gain despite diet and exercise The critical role of AMPK (AMP-activated protein kinase) in regulating metabolism and fat …

CN Announces Election of Directors

CN Announces Election of Directors

MONTREAL, May 02, 2025 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) announced that the director nominees listed in the management information circular dated March 10, 2025 (the “Information Circular”), were elected as directors of CN. The detailed results …

Le CN annonce l’élection des administrateurs

Le CN annonce l’élection des administrateurs

MONTRÉAL, 02 mai 2025 (GLOBE NEWSWIRE) -- Le CN (TSX : CNR) (NYSE : CNI) a annoncé que les candidats aux postes d’administrateurs proposés dans la Circulaire de sollicitation de procurations du 10 mars 2025 (la Circulaire) ont été élus administrateurs du …

Neuro Fortis PRO Under Review: Neuro Activation Formula to Reverse Brain Shrinkage & Cognitive Decline

Neuro Fortis PRO Under Review: Neuro Activation Formula to Reverse Brain Shrinkage & Cognitive Decline

New York, May 02, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: The rising concern around early-onset brain shrinkage and how it impacts memory, focus, and cognitive energy What causes cognitive decline and the common risk factors accelerating …

Just Blood Uncovers New Blood Testing Technology

Just Blood Uncovers New Blood Testing Technology

NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- In a much-anticipated live demonstration on April 30, 2025, Laboratory expert and entrepreneur Ryan El-Hosseiny shut down Times Square in New York to unveil a new blood testing technology that he believes could …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service